- Home
- CODA vs ANEB Comparison
CODA vs ANEB Comparison
Compare CODA & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODA
- ANEB
- Stock Information
- Founded
- CODA 1994
- ANEB 2020
- Country
- CODA United States
- ANEB United States
- Employees
- CODA N/A
- ANEB N/A
- Industry
- CODA Industrial Machinery/Components
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- CODA Industrials
- ANEB Health Care
- Exchange
- CODA Nasdaq
- ANEB Nasdaq
- Market Cap
- CODA 88.8M
- ANEB 90.4M
- IPO Year
- CODA N/A
- ANEB 2021
- Fundamental
- Price
- CODA $8.76
- ANEB $2.37
- Analyst Decision
- CODA Strong Buy
- ANEB Buy
- Analyst Count
- CODA 1
- ANEB 2
- Target Price
- CODA $11.00
- ANEB $8.00
- AVG Volume (30 Days)
- CODA 66.2K
- ANEB 124.1K
- Earning Date
- CODA 09-15-2025
- ANEB 11-12-2025
- Dividend Yield
- CODA N/A
- ANEB N/A
- EPS Growth
- CODA 21.86
- ANEB N/A
- EPS
- CODA 0.30
- ANEB N/A
- Revenue
- CODA $22,758,966.00
- ANEB N/A
- Revenue This Year
- CODA $30.82
- ANEB N/A
- Revenue Next Year
- CODA $20.84
- ANEB N/A
- P/E Ratio
- CODA $29.09
- ANEB N/A
- Revenue Growth
- CODA 24.78
- ANEB N/A
- 52 Week Low
- CODA $5.76
- ANEB $0.80
- 52 Week High
- CODA $9.89
- ANEB $3.42
- Technical
- Relative Strength Index (RSI)
- CODA 66.55
- ANEB 50.03
- Support Level
- CODA $7.61
- ANEB $1.77
- Resistance Level
- CODA $8.12
- ANEB $2.26
- Average True Range (ATR)
- CODA 0.40
- ANEB 0.19
- MACD
- CODA 0.05
- ANEB -0.05
- Stochastic Oscillator
- CODA 96.43
- ANEB 53.10
About CODA Coda Octopus Group Inc. Common stock
Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company's operations are organized into two reportable segments: the Products Segment (Marine Technology Business serving the subsea market and PAL, which sells other products (acoustic hydrophones and acoustic materials to a different market); and the Services Segment (Marine Engineering Business). Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.